MMG
AZN icon

Monetary Management Group’s AstraZeneca AZN Stock Holding History

Monetary Management Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$542K Sell
2,750
-375
-12% -$72.3K 0.13% 139
2025
Q4 		$575K Buy
3,125
+375
+14% +$65.8K 0.13% 131
2025
Q3 		$422K Hold
2,750
– – 0.1% 159
2025
Q2 		$384K Hold
2,750
– – 0.09% 160
2025
Q1 		$404K Hold
2,750
– – 0.11% 151
2024
Q4 		$360K Sell
2,750
-1,000
-27% -$140K 0.09% 158
2024
Q3 		$584K Buy
3,750
+1,000
+36% +$161K 0.15% 130
2024
Q2 		$429K Hold
2,750
– – 0.11% 149
2024
Q1 		$373K Hold
2,750
– – 0.1% 158
2023
Q4 		$370K Hold
2,750
– – 0.12% 148
2023
Q3 		$372K Hold
2,750
– – 0.12% 146
2023
Q2 		$394K Hold
2,750
– – 0.12% 147
2023
Q1 		$382K Hold
2,750
– – 0.11% 148
2022
Q4 		$373K Hold
2,750
– – 0.12% 147
2022
Q3 		$302K Hold
2,750
– – 0.1% 157
2022
Q2 		$363K Hold
2,750
– – 0.11% 141
2022
Q1 		$365K Hold
2,750
– – 0.1% 149
2021
Q4 		$320K Hold
2,750
– – 0.08% 161
2021
Q3 		$330K Hold
2,750
– – 0.09% 158
2021
Q2 		$329K Hold
2,750
– – 0.1% 150
2021
Q1 		$273K Buy
2,750
+1,000
+57% +$101K 0.09% 153
2020
Q4 		$175K Hold
1,750
– – 0.06% 171
2020
Q3 		$192K Hold
1,750
– – 0.07% 160
2020
Q2 		$185K Hold
1,750
– – 0.07% 149
2020
Q1 		$156K Sell
1,750
-250
-13% -$23.5K 0.07% 148
2019
Q4 		$199K Hold
2,000
– – 0.07% 158
2019
Q3 		$178K Hold
2,000
– – 0.07% 171
2019
Q2 		$165K Hold
2,000
– – 0.06% 168
2019
Q1 		$162K Hold
2,000
– – 0.06% 170
2018
Q4 		$152K Hold
2,000
– – 0.07% 160
2018
Q3 		$158K Hold
2,000
– – 0.06% 168
2018
Q2 		$140K Sell
2,000
-750
-27% -$54K 0.06% 174
2018
Q1 		$192K Hold
2,750
– – 0.08% 145
2017
Q4 		$191K Hold
2,750
– – 0.08% 155
2017
Q3 		$186K Hold
2,750
– – 0.08% 154
2017
Q2 		$187K Sell
2,750
-500
-15% -$32.7K 0.08% 158
2017
Q1 		$202K Sell
3,250
-125
-4% -$7.28K 0.09% 150
2016
Q4 		$184K Sell
3,375
-400
-11% -$22.7K 0.09% 146
2016
Q3 		$248K Hold
3,775
– – 0.11% 132
2016
Q2 		$228K Sell
3,775
-600
-14% -$34.9K 0.11% 135
2016
Q1 		$246K Sell
4,375
-750
-15% -$45.1K 0.12% 128
2015
Q4 		$348K Hold
5,125
– – 0.17% 109
2015
Q3 		$326K Sell
5,125
-500
-9% -$32.9K 0.16% 116
2015
Q2 		$358K Sell
5,625
-1,000
-15% -$68.5K 0.16% 117
2015
Q1 		$453K Sell
6,625
-750
-10% -$52.1K 0.2% 99
2014
Q4 		$519K Sell
7,375
-4,100
-36% -$294K 0.23% 97
2014
Q3 		$820K Buy
11,475
+4,250
+59% +$311K 0.38% 80
2014
Q2 		$537K Buy
7,225
+5,625
+352% +$407K 0.25% 96
2014
Q1 		$104K Sell
1,600
-150
-9% -$9.69K 0.05% 182
2013
Q4 		$104K Buy
+1,750
New +$95.1K 0.05% 193

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Monetary Management Group's AZN Position: Q1 2026 in Review

Monetary Management Group reduced its AstraZeneca (AZN) stake by 12% in Q1 2026, selling an estimated $72.3K and leaving 2,750 shares worth $542K. The position accounts for 0.13% of the portfolio, ranked #139.

Monetary Management Group first reported a position in AZN in Q4 2013 and has held it in 50 quarters since. The position peaked at $820K in Q3 2014. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Monetary Management Group held 2,750 shares of AstraZeneca worth $542K as of Q1 2026.
  • Monetary Management Group sold 375 AstraZeneca shares in Q1 2026, an estimated $72.3K.
  • AstraZeneca made up 0.13% of Monetary Management Group's portfolio in Q1 2026, its #139 holding.
  • Monetary Management Group first reported a position in AstraZeneca in Q4 2013 and has held it in 50 quarters since.
  • Monetary Management Group's AstraZeneca position peaked at $820K in Q3 2014.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Monetary Management Group's 13F filing for Q1 2026, filed 13 May 2026.